Current challenges and clinical investigations of epidermal growth factor receptor (EGFR)- and ErbB family-targeted agents in the treatment of head and neck squamous cell carcinoma (HNSCC)-Reference-Cited by-同舟云学术

Current challenges and clinical investigations of epidermal growth factor receptor (EGFR)- and ErbB family-targeted agents in the treatment of head and neck squamous cell carcinoma (HNSCC)

Published:2014-05 Issue:4 Volume:40 Page:567-577
ISSN:0305-7372
Container-title:Cancer Treatment Reviews
language:en
Short-container-title:Cancer Treatment Reviews

Author:

Cohen Roger B.

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Reference113 articles.

1. Cancer facts and figures, 2013;American Cancer Society,2013

2. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology™. Head and Neck Cancers. V.2.2013. .

3. Role of epidermal growth factor receptor pathway-targeted therapy in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck;Cohen;J Clin Oncol,2006

4. ERBITUX® (cetuximab) injection, for intravenous infusion [package insert]. Branchburg, NJ: ImClone LLC; 2013.

5. Optimal treatment for recurrent/metastatic head and neck cancer;Vermorken;Ann Oncol,2010

Cited by 115 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Randomized phase II study of preoperative afatinib in untreated head and neck cancers: predictive and pharmacodynamic biomarkers of activity;Scientific Reports;2023-12-18

2. Randomized phase II study of preoperative Afatinib in untreated head and neck cancers: predictive and pharmacodynamic biomarkers of efficacy;2023-08-25

3. Significance of EGFR investigation in odontogenic keratocyst: a narrative review;Molecular Biology Reports;2023-06-14

4. Repurposing Dihydroartemisinin to Combat Oral Squamous Cell Carcinoma, Associated with Mitochondrial Dysfunction and Oxidative Stress;Oxidative Medicine and Cellular Longevity;2023-02-16

5. An integrative approach toward identification and analysis of therapeutic targets involved in HPV pathogenesis with a focus on carcinomas;Cancer Biomarkers;2023-01-20